Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pliant Therapeutics Inc shares valued at $587,150 were sold by Coulie Bernard on Jan 17 ’25. At $11.20 per share, Coulie Bernard sold 52,419 shares. The insider’s holdings dropped to 430,517 shares worth approximately $4.7 million following the completion of this transaction.
Also, Cummings Keith Lamont sold 20,148 shares, netting a total of over 225,680 in proceeds. Following the sale of shares at $11.20 each, the insider now holds 262,608 shares.
Before that, Hull Hans had sold 15,936 shares from its account. In a trade valued at $178,501, the Chief Business Officer traded Pliant Therapeutics Inc shares for $11.20 each. Upon closing the transaction, the insider’s holdings decreased to 15,936 shares, worth approximately $2.31 million.
Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of May 18, 2023, Canaccord Genuity has initiated its “Buy” rating for PLRX. Earlier on April 13, 2023, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PLRX stock.
Analyzing PLRX Stock Performance
During the last five days, there has been a drop of approximately -2.85%. Over the course of the year, Pliant Therapeutics Inc shares have dropped approximately -17.08%. Shares of the company reached a 52-week high of $13.71 on 01/03/25 and a 52-week low of $10.78 on 01/22/25. A 50-day SMA is recorded $13.34, while a 200-day SMA reached $12.93. Nevertheless, trading volume fell to 0.7 million shares from 0.68 million shares the previous day.
Support And Resistance Levels for Pliant Therapeutics Inc (PLRX)
According to the 24-hour chart, there is a support level at 10.72, which, if violated, would cause prices to drop to 10.51. In the upper region, resistance lies at 11.19. The next price resistance is at 11.45. RSI (Relative Strength Index) is 35.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.18, which suggests the price will decrease in the coming days. Percent R is at 95.22%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
